ProShare Advisors LLC Sells 66,392 Shares of Cardinal Health, Inc. $CAH

ProShare Advisors LLC lessened its stake in shares of Cardinal Health, Inc. (NYSE:CAHFree Report) by 6.0% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,042,058 shares of the company’s stock after selling 66,392 shares during the quarter. ProShare Advisors LLC owned about 0.44% of Cardinal Health worth $214,143,000 as of its most recent filing with the SEC.

Other large investors also recently made changes to their positions in the company. Integrated Wealth Concepts LLC boosted its stake in Cardinal Health by 6.9% during the 1st quarter. Integrated Wealth Concepts LLC now owns 4,363 shares of the company’s stock valued at $601,000 after purchasing an additional 280 shares during the period. Jones Financial Companies Lllp boosted its stake in Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after purchasing an additional 14,034 shares during the period. Arrowstreet Capital Limited Partnership bought a new stake in Cardinal Health during the 2nd quarter valued at approximately $1,935,000. Cerity Partners LLC boosted its stake in Cardinal Health by 17.0% during the 2nd quarter. Cerity Partners LLC now owns 40,426 shares of the company’s stock valued at $6,792,000 after purchasing an additional 5,880 shares during the period. Finally, Nebula Research & Development LLC boosted its stake in Cardinal Health by 34.4% during the 2nd quarter. Nebula Research & Development LLC now owns 10,334 shares of the company’s stock valued at $1,736,000 after purchasing an additional 2,646 shares during the period. Institutional investors own 87.17% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on CAH. Jefferies Financial Group increased their target price on Cardinal Health from $220.00 to $270.00 and gave the company a “buy” rating in a research note on Thursday, January 22nd. Wells Fargo & Company decreased their target price on Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a research note on Friday, May 1st. Leerink Partners restated an “outperform” rating and set a $275.00 target price on shares of Cardinal Health in a research note on Monday, March 9th. Wall Street Zen upgraded Cardinal Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday, May 2nd. Finally, William Blair assumed coverage on Cardinal Health in a research report on Tuesday, April 28th. They issued an “outperform” rating for the company. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $241.80.

Check Out Our Latest Stock Analysis on CAH

Cardinal Health Trading Up 2.4%

Shares of CAH opened at $199.90 on Tuesday. Cardinal Health, Inc. has a 1 year low of $137.75 and a 1 year high of $233.60. The stock has a 50 day simple moving average of $206.64 and a 200-day simple moving average of $208.36. The stock has a market cap of $46.82 billion, a PE ratio of 30.57, a PEG ratio of 1.16 and a beta of 0.53.

Cardinal Health (NYSE:CAHGet Free Report) last issued its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The business had revenue of $60.94 billion during the quarter, compared to analysts’ expectations of $62.10 billion. During the same period in the prior year, the firm posted $2.35 EPS. Cardinal Health’s quarterly revenue was up 11.0% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, sell-side analysts forecast that Cardinal Health, Inc. will post 10.76 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be issued a $0.5158 dividend. This represents a $2.06 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date of this dividend is Wednesday, July 1st. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s payout ratio is currently 31.19%.

Cardinal Health Company Profile

(Free Report)

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

Further Reading

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAHFree Report).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.